
Tumors spread to lymph nodes before they metastasize to distant tissues, but for over a century scientists have debated whether this matters. It does. Check out our paper online now @CellCellPress @CellPressNews cell.com/cell/fulltext/S0092… 1/15

Tumor Immunologist and Engineer @Stanford.

Tumors spread to lymph nodes before they metastasize to distant tissues, but for over a century scientists have debated whether this matters. It does. Check out our paper online now @CellCellPress @CellPressNews cell.com/cell/fulltext/S0092… 1/15

Finishing your PhD or looking for a post-bac research position? We’re recruiting multiple postdocs and research technicians to study somatic evolution! Come do interdisciplinary science in a friendly, collaborative environment at @harvardmed Genetics. naxerova.hms.harvard.edu/con…

If you're interested in hearing about lymph node metastasis, tumor evolution, T cells, and immunotherapy, check out this @theNCI forum tomorrow, featuring Mary Jo Turk, @naxerova, and Alexander Huang. events.cancer.gov/dcb/tdln #TDLNForums

When tumors colonize lymph nodes, they induce a LOT of changes to the immune and stromal populations in the involved LN and beyond, throughout the induction of Metastatic Tolerance. Check out this great study and rich resource describing these changes. Congrats @Max_Haist !
Online Now: Lymph node colonization induces tissue remodeling via immunosuppressive fibroblast-myeloid cell niches supporting metastatic tolerance dlvr.it/TQflcw

Happy to share our latest @sigtrans_sttt commentary on two beautiful @Nature papers on #ferroptosis and #cancer. Kudos to these 2 teams for their beautiful work! @j_ubellacker @luciaborriell @FoxChaseCancer nature.com/articles/s41392-0…

Thanks to @NatRevImmunol and the @preprintclub for highlighting our recent study on divergent evolution and type I interferon
Type I interferon at the crossroads of metastatic dissemination bit.ly/44XMMuS

Evolution Under Therapy: Resistance Mechanisms— Andrew J. Aguirre, Nathan E. Reticker-Flynn, Susan M. Rosenberg, and Kathleen Burkhardt addressed this topic in a plenary session at the AACR Special Conference on Cancer Evolution. #AACRevol25 @RetickerFlynn @SusanRosenberg8

What if nature already has the optimal cytokine solution for T cell therapy, but we just haven’t found it yet? Check out our paper out today in Immunity on IL-9 as a naturally orthogonal cytokine ideally tuned for T cell therapy authors.elsevier.com/sd/arti… 1/9

Nature research paper: Lymph node environment drives FSP1 targetability in metastasizing melanoma go.nature.com/4oiPnY2

Thrilled to see Mario's work on FSP1 out, providing evidence in melanoma alongside lung cancer that there may be alternatives for targeting ferroptosis! Glad we could help with this work including providing our LN metastasis model for in vivo validation
Nature research paper: Lymph node environment drives FSP1 targetability in metastasizing melanoma go.nature.com/4oiPnY2

Therapeutic benefit of intratumoral inhibition of FSP1 & ferroptosis in pre-clinical lung cancer and versus melanoma growth in lymph nodes @Nature @ThalesPapaG @nyugrossman @HarvardEpi nature.com/articles/s41586-0… nature.com/articles/s41586-0…

Two new Nature papers show that inhibiting FSP1 is sufficient to restrict tumor growth in vivo, a major step forward for ferroptosis-targeted cancer therapy. Huge congrats to all authors! nature.com/articles/s41586-0… nature.com/articles/s41586-0… #Ferroptosis #FSP1 #CancerResearch

Evolution Under Therapy: Resistance Mechanisms— Andrew J. Aguirre, Nathan E. @RetickerFlynn, @SusanRosenberg8, and Kathleen Burkhardt will address this topic in a plenary at the AACR Conference on Cancer Evolution (Dec 4-6; Albuquerque). brnw.ch/21wWYfD #AACRevol25

See the tweetorial from @CortBreuer ☝️and the preprint 👇 biorxiv.org/content/10.1101/…

Tumors often metastasize to lymph nodes before distant sites, yet evidence suggests that distant mets can originate from unique clones. Is this divergent seeding random? No. Check out our newest @biorxivpreprint to learn how the mechanisms diverge and how to harness them for IO.
I’m excited to share the first major story from my PhD today on the complex role of type 1 interferon in metastasis and immunotherapy! This work was made possible with the support of @RetickerFlynn, Marcos Labrado, and the incredible protein engineer @grayerodriguez

Pleasure to share a tremendous body of work from @YangZhao102, who led the next chapter of the powerful orthogonal IL-2 technology from the Garcia Lab (where the innovative spirit is unmatched). Grateful for this ongoing collaboration, stay tuned for more. rdcu.be/eACgC